Abstract
In order to image the distribution of spread of metastases from a primary adenocarcinoma in a patient using radioimmunoscintigraphy, a combination of four factors is required: an antibody specific to the cancer in question; a radiolabel that is optimal for the imaging system and for the kinetics of antibody uptake; a method of labeling the antibody and quality control so that is is suitable for injection into the patient; and, a gamma camera imaging system that enables the distribution of the radiolabeled antibody to be visualized to the best advantage. Although it is evident that the major limitation of the current practice of radioimmunoscintigraphy is the inability to get sufficient numbers of a sufficiently specific antibody on to all the cancer cells that have spread from the primary site, this paper is concerned with the other three requirements: the radiolabel, the labeling method, and the imaging of its distribution, with particular reference to the use of iodine-123.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Berche, C., Mach, J.P., Lambroso, J.D., Langlais, C., Aubry, F., Buchegger, F., Carrel, S., Rouigier, P., Parmentier, D., and Tubiana, M., 1982, Tomoscintigraphy for detection of gastrointestinal and medullary thyroid cancers. First clinical results using radiolabelled monoclonal antibodies against carcinoembryonic antigen. Brit. Med. J., 285: 1447.
Bett, R., Cuninghame, J. G., Hill, J.I.S., Jones, I.G., Taylor, N.K., and Winter, J.A., 1980, Development of a process for routine production of I-125 using the I-127 (p, 5n) 123-Xe→123-I reaction. J. Radioanal. Chem. 56: 237.
Buraggi, G.L., Turrin, A., Cascinelli, N., Attili, A., Terno, G., Bombardierei, E., Gasparini, M., and Seregni, E., 1985, Immunoscintigraphy with antimelanoma monoclonal antibodies. In: “Immunoscintigraphy” L. Donato & K.E. Britton, Eds. 215–253, Monographs in Nuclear Medicine Volume 1, P. Cox, Ed. Gordon & Breach, London.
Davies, J.O., Davies, E.R., Howe, K., Jackson, P.C., Pitcher, E.M., Sadowski , C.S.. Stirrat, G.M., and Sunderland, C.A., 1985, Radionuclide imaging of ovarian -tumours with I-123 labelled monoclonal antibody. Brit. J. Obstet. Gynaecol. 92:277.
Epenetos, A.A., Britton, K.E., Mather, S., Shepherd, J., Granowska, M., Taylor-Papadimitriou, J., Nimmon, C.C., Durbin, H., Hawkins, L.A., Malpas, J.S., and Bodmer, W.F., 1982, Targetting of Iodine-123 labelled tumour associated monoclonal antibodies to ovarian, breast and intestinal tumours. Lancet, ii:999.
Fraker, P.J., and Speek, J.C., 1978, Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1, 3, 4, 6-tetra-chloro-3a, 6a-diphenylglycoluril. 80:849.
Goldman, A., Vivian, G., Gordon, I., Pritchard, J., and Kemshead, J.T., 1984, Immunolocalisation of neuroblastoma using radiolabelled monoclonal antibody UJ13A. J. Paediat. 105:252.
Granowska, M., and Britton, K.E., 1986c, A strategic approach to radio-immunoscintigraphy in ovarian and colorectal cancer. In: “Radioaktive isotope in klinik und forschung” Vol. 17, 377–381. Gasteimer Int. Symp. 1986, R. Hofer and H. Bergman, Eds. Egermann Verlag, Vienna.
Granowska, M., Britton, K.E., Shepherd, J., 1984a, The detection of ovarian cancer using I-123 monoclonal antibody. Radiobiol. Radiother. (Berl) 25: 153.
Granowska, M., Britton, K.E., Shepherd, J.H., Nimmon, C.C., Mather, S., Ward, B., Osborne, R.J., and Slevin, M.L., 1986b, A prospective study of I-123 labelled monoclonal antibody imaging in ovarian cancer. J. Clin. Onc. 4: 730.
Granowska, M., Nimmon, C.C. and Britton, K.E., 1986a, Immunoscintigraphy of ovarian cancer by means of HMFG2 monoclonal antibody. In: “Nuclear medicine in clinical oncology”, 171–174, C. Winkler, Ed. Springer-Verlag, Berlin.
Granowska, M., Shepherd, J., Britton, K.E., Ward, B., Mather, S., Taylor-Papadimitriou, J., Epenetos, A.A., Carroll, M.J., Nimmon, C.C., Hawkins, L.A., Flatman, W.D., Home, T., and Bodmer, W.F., 1984b, Ovarian cancer: diagnosis using 123-I monoclonal antibody in comparison with surgical findings. Nucl. Med. Commun. 5:485.
Home, T., Granowska, M., Dicks-Mireaux, C., Hawkins, L.A., Britton, K.E., Mather, S., Bomanji, J., Kemshead, J.T., Kingston, J., and Malpas, J.S., 1985, Neuroblastoma imaged with I-123 meta iodo benzyl guanidine and with I-123 labelled monoclonal antibody, UJ13A, against neural tissue. Brit. J. Radiol., 58: 476.
Miller, W.T., and Smith, J.F.G., 1983, Protein iodination using iodogen. Int. J. Appl. Radiat. Isot., 34: 639.
Ott, R.J., Grey, L.J., Zivanovic, M.A., Flower, M.A., Trott, N.G., Moshakis, V., Coombes, R.C., Neville, A.M., Ormerod, M.G., and Westwood, J.H., 1983, The limitations of the dual radionuclide subtraction technique for the external detection of tumours by radioiodine labelled antibodies. Brit. J. Radiol., 56: 101.
Pateisky, N., Philipp, K., Skodler, W.D., Czerwenka, K., Hamilton, G., and Burchell, J., 1985, Radioimmunodetection in patients with suspected ovarian cancer. J. Nucl. Med., 26: 1369.
Taylor-Papadimitriou, J., Peterson, J.A., Arklie, J., Burchell, J., Ceriani, R.C., and Bodmer, W.F., 1981, Monoclonal antibodies to epithelium specific components of the human milk fat globulin membrane: production and reaction with cells in culture. Int. J. Cancer, 28: 17.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Springer Science+Business Media New York
About this paper
Cite this paper
Britton, K., Granowska, M. (1988). Experience with Iodine-123 Labeled Antibodies. In: Srivastava, S.C. (eds) Radiolabeled Monoclonal Antibodies for Imaging and Therapy. NATO ASI Series, vol 152. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5538-0_14
Download citation
DOI: https://doi.org/10.1007/978-1-4684-5538-0_14
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-5540-3
Online ISBN: 978-1-4684-5538-0
eBook Packages: Springer Book Archive